These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 2611527)

  • 1. The effect of cromakalim on kidney function in the anaesthetised rat.
    Johns EJ; Marriott I
    Br J Pharmacol; 1989 Dec; 98 Suppl():821P. PubMed ID: 2611527
    [No Abstract]   [Full Text] [Related]  

  • 2. [Potassium agonists: regional vasodilator profile in rats].
    Richer C; Mulder P; Doussau MP; Giudicelli JF
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1333-7. PubMed ID: 2510669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of BRL 38227 on the adrenergic regulation of the kidney vasculature of the rat.
    Johns EJ
    Eur J Pharmacol; 1993 Jan; 230(1):47-51. PubMed ID: 8428603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the haemodynamic profiles of Ro 31-6930, cromakalim and nifedipine in anaesthetised normotensive rats.
    Duty S; Paciorek PM; Waterfall JF; Weston AH
    Eur J Pharmacol; 1990 Aug; 185(1):35-42. PubMed ID: 2226633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary vascular and renal effects of cromakalim in anaesthetized dogs.
    Hicks PE; Martin D; Dumez D; Zazzi-Sudriez E; Armstrong JM
    Pflugers Arch; 1989; 414 Suppl 1():S192-3. PubMed ID: 2780259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism.
    Grover GJ; D'Alonzo AJ; Sleph PG; Dzwonczyk S; Hess TA; Darbenzio RB
    J Pharmacol Exp Ther; 1994 May; 269(2):536-40. PubMed ID: 8182522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cromakalim suppresses hypertonic saline-induced renal vasoconstriction in anaesthetized dogs.
    Ogasawara A; Hirano T; Hisa H; Satoh S
    Clin Exp Pharmacol Physiol; 1995 Apr; 22(4):311-3. PubMed ID: 7671451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intracavernous injection of potassium channel openers in monkeys and dogs.
    Trigo-Rocha F; Donatucci CF; Hsu GL; Nunes L; Lue TF; Tanagho EA
    Int J Impot Res; 1995 Mar; 7(1):41-8. PubMed ID: 7670592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hydraulic impedance response to cromakalim (BRL 34915) in newborn pigs.
    Domkowski PW; Cockerham JT; Kot PA; Shaffer RF; Fazzone AB; Messier RH; Wallace RB; Hopkins RA
    J Surg Res; 1994 Jun; 56(6):626-35. PubMed ID: 8015321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive effects of the novel potassium channel activator SKP-450 and its major metabolites in rats.
    Shin HS; Seo HW; Oh JH; Lee BH
    Arzneimittelforschung; 1998 Oct; 48(10):969-78. PubMed ID: 9825113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence against a cytochrome P450-derived reactive oxygen species as the mediator of the nitric oxide-independent vasodilator effect of bradykinin in the perfused heart of the rat.
    Fulton D; McGiff JC; Wolin MS; Kaminski P; Quilley J
    J Pharmacol Exp Ther; 1997 Feb; 280(2):702-9. PubMed ID: 9023282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The haemodynamic profile of cromakalim in the cat.
    Clapham JC; Buckingham RE
    J Cardiovasc Pharmacol; 1988; 12(5):555-61. PubMed ID: 2468055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cromakalim differentially enhances antinociception induced by agonists of alpha(2)adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors.
    Ocaña M; Barrios M; Baeyens JM
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1136-42. PubMed ID: 8786544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to cromakalim in the rat uterus in vivo.
    Downing SJ; Miller M; Hollingsworth M
    Br J Pharmacol; 1989 Mar; 96(3):732-8. PubMed ID: 2720301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal side-effects of cyclosporine.
    Mason J
    Transplant Proc; 1990 Jun; 22(3):1280-3. PubMed ID: 2190390
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of inhaled cromakalim and its active enantiomer BRL 38277 as bronchodilators in the guinea-pig.
    Bowring NE; Taylor JF; Francis GR; Arch JR
    Br J Pharmacol; 1989 Dec; 98 Suppl():805P. PubMed ID: 2611518
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of cromakalim on micturition function in rats.
    Smith AB; Bertelsen DL; Kau ST; Chun AL
    Neurourol Urodyn; 1993; 12(1):99-108. PubMed ID: 8481733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of novel vasodilator long chain acyl carnitine esters in the isolated perfused heart of the rat.
    Criddle DN; Dewar GH; Wathey WB; Woodward B
    Br J Pharmacol; 1990 Mar; 99(3):477-80. PubMed ID: 1691947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sandimmun metabolites: their potential to cause adverse reactions in the rat.
    Donatsch P; Rickenbacher U; Ryffel B; Brouillard JF
    Transplant Proc; 1990 Jun; 22(3):1137-40. PubMed ID: 2349675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.